Skip to main content
Top
Published in: Endocrine 1/2015

01-02-2015 | Endocrine Genetics/Epigenetics

Von Hippel-Lindau disease type 2 in a Chinese family with a VHL p.W88X truncation

Authors: Min Zhang, Jie Wang, Jingjing Jiang, Xiaohui Zhan, Yan Ling, Zhiqiang Lu, Jianming Guo, Xin Gao

Published in: Endocrine | Issue 1/2015

Login to get access

Abstract

Von Hippel-Lindau (VHL) disease is an autosomal dominant syndrome caused by germline mutations in the synonymous VHL gene encoding a tumor suppressor. Affected individuals are susceptible to various benign and malignant tumors. Based on the phenotypes, VHL disease is classified as type 1 and type 2. Here, we describe a Chinese family diagnosed as VHL disease type 2, with different metabolic status of tumors on FDG PET-CT. Genetic analysis revealed a germline c.264G > A point mutation, resulting in premature termination at codon 88 (p.W88X). This pedigree represents a rare link between p.W88X nonsense mutation (genotype) and VHL disease type 2 (phenotype), which has not been previously described. This is also the first nonsense mutation to manifest as VHL disease type 2 in ethnic Chinese. We also reviewed the literature and provided an outline of mutations associated with VHL disease in China.
Appendix
Available only for authorised users
Literature
1.
go back to reference F. Latif, K. Tory, J. Gnarra, M. Yao, F.M. Duh, M.L. Orcutt, T. Stackhouse, I. Kuzmin, W. Modi, L. Geil et al., Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260, 1317–1320 (1993)CrossRefPubMed F. Latif, K. Tory, J. Gnarra, M. Yao, F.M. Duh, M.L. Orcutt, T. Stackhouse, I. Kuzmin, W. Modi, L. Geil et al., Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260, 1317–1320 (1993)CrossRefPubMed
2.
go back to reference R.R. Lonser, G.M. Glenn, M. Walther, E.Y. Chew, S.K. Libutti, W.M. LinehanE, H. Oldfield, Von Hippel-Lindau disease. Lancet 361, 2059–2067 (2003)CrossRefPubMed R.R. Lonser, G.M. Glenn, M. Walther, E.Y. Chew, S.K. Libutti, W.M. LinehanE, H. Oldfield, Von Hippel-Lindau disease. Lancet 361, 2059–2067 (2003)CrossRefPubMed
3.
go back to reference T. Mete, D. Berker, E. Yilmaz, G. Ozgen, Y. Yalcin, M. Tuna, D. Ciliz, M. Onen, Y. AydinS, S. Guler, Clinical presentation of von Hippel Lindau syndrome type 2B associated with VHL p. A149S mutation in a large Turkish family. Endocrine 45, 128–135 (2014)CrossRefPubMed T. Mete, D. Berker, E. Yilmaz, G. Ozgen, Y. Yalcin, M. Tuna, D. Ciliz, M. Onen, Y. AydinS, S. Guler, Clinical presentation of von Hippel Lindau syndrome type 2B associated with VHL p. A149S mutation in a large Turkish family. Endocrine 45, 128–135 (2014)CrossRefPubMed
4.
go back to reference B. Zbar, T. Kishida, F. Chen, L. Schmidt, E.R. Maher, F.M. Richards, P.A. Crossey, A.R. Webster, N.A. Affara, M.A. Ferguson-Smith, H. Brauch, D. Glavac, H.P. Neumann, S. Tisherman, J.J. Mulvihill, D.J. Gross, T. Shuin, J. Whaley, B. Seizinger, N. Kley, S. Olschwang, C. Boisson, S. Richard, C.H. Lips, M. Lerman et al., Germline mutations in the von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum. Mutat. 8, 348–357 (1996)CrossRefPubMed B. Zbar, T. Kishida, F. Chen, L. Schmidt, E.R. Maher, F.M. Richards, P.A. Crossey, A.R. Webster, N.A. Affara, M.A. Ferguson-Smith, H. Brauch, D. Glavac, H.P. Neumann, S. Tisherman, J.J. Mulvihill, D.J. Gross, T. Shuin, J. Whaley, B. Seizinger, N. Kley, S. Olschwang, C. Boisson, S. Richard, C.H. Lips, M. Lerman et al., Germline mutations in the von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum. Mutat. 8, 348–357 (1996)CrossRefPubMed
5.
go back to reference A. Porollo, J. Meller, Versatile annotation and publication quality visualization of protein complexes using POLYVIEW-3D. BMC Bioinform. 8, 316 (2007)CrossRef A. Porollo, J. Meller, Versatile annotation and publication quality visualization of protein complexes using POLYVIEW-3D. BMC Bioinform. 8, 316 (2007)CrossRef
6.
go back to reference H. Li, B. Handsaker, A. Wysoker, T. Fennell, J. Ruan, N. Homer, G. Marth, G. Abecasis, R. DurbinS, Genome project DATA Processing, the sequence alignment/map format and samtools. Bioinform. 25, 2078–2079 (2009)CrossRef H. Li, B. Handsaker, A. Wysoker, T. Fennell, J. Ruan, N. Homer, G. Marth, G. Abecasis, R. DurbinS, Genome project DATA Processing, the sequence alignment/map format and samtools. Bioinform. 25, 2078–2079 (2009)CrossRef
7.
go back to reference R. Li, Y. Li, X. Fang, H. Yang, J. Wang, K. Kristiansen, J. Wang, SNP detection for massively parallel whole-genome resequencing. Genome Res. 19, 1124–1132 (2009)CrossRefPubMedCentralPubMed R. Li, Y. Li, X. Fang, H. Yang, J. Wang, K. Kristiansen, J. Wang, SNP detection for massively parallel whole-genome resequencing. Genome Res. 19, 1124–1132 (2009)CrossRefPubMedCentralPubMed
8.
go back to reference D.E. Kang, R.L. White Jr, J.H. Zuger, H.C. SasserC, M. Teigland, Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma. J. Urol. 171, 1806–1809 (2004)CrossRefPubMed D.E. Kang, R.L. White Jr, J.H. Zuger, H.C. SasserC, M. Teigland, Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma. J. Urol. 171, 1806–1809 (2004)CrossRefPubMed
9.
go back to reference S. Solav, R. Bhandari, Fluorodeoxyglucose positron emission tomography-computed tomography scan in von Hippel-Lindau syndrome: a case report and review of literature. Indian J. Nucl. Med. 27, 119–121 (2012)CrossRefPubMedCentralPubMed S. Solav, R. Bhandari, Fluorodeoxyglucose positron emission tomography-computed tomography scan in von Hippel-Lindau syndrome: a case report and review of literature. Indian J. Nucl. Med. 27, 119–121 (2012)CrossRefPubMedCentralPubMed
10.
go back to reference J. Zhang, Y. Huang, J. Pan, D. Liu, L. Zhou, W. Xue, Q. Chen, B. Dong, H. Xuan, Germline mutations in the von Hippel-Lindau disease (VHL) gene in mainland Chinese families. J. Cancer Res. Clin. Oncol. 134, 1211–1218 (2008)CrossRefPubMed J. Zhang, Y. Huang, J. Pan, D. Liu, L. Zhou, W. Xue, Q. Chen, B. Dong, H. Xuan, Germline mutations in the von Hippel-Lindau disease (VHL) gene in mainland Chinese families. J. Cancer Res. Clin. Oncol. 134, 1211–1218 (2008)CrossRefPubMed
11.
go back to reference W.K. Siu, R.C. Ma, C.W. Lam, C.M. Mak, Y.P. Yuen, F.M. Lo, K.W. Chan, S.F. Lam, S.C. Ling, S.F. Tong, W.Y. So, C.C. Chow, M.H. Tang, W.H. TamA, Y. Chan, Molecular basis of von Hippel-Lindau syndrome in Chinese patients. Chin. Med. J. (Engl) 124, 237–241 (2011) W.K. Siu, R.C. Ma, C.W. Lam, C.M. Mak, Y.P. Yuen, F.M. Lo, K.W. Chan, S.F. Lam, S.C. Ling, S.F. Tong, W.Y. So, C.C. Chow, M.H. Tang, W.H. TamA, Y. Chan, Molecular basis of von Hippel-Lindau syndrome in Chinese patients. Chin. Med. J. (Engl) 124, 237–241 (2011)
12.
go back to reference Y. Huang, D. Zhou, J. Liu, P. Zhou, X. LiZ, Z. Wang, Germline mutations of the VHL gene in seven Chinese families with von Hippel-Lindau disease. Int. J. Mol. Med. 29, 47–52 (2012)PubMed Y. Huang, D. Zhou, J. Liu, P. Zhou, X. LiZ, Z. Wang, Germline mutations of the VHL gene in seven Chinese families with von Hippel-Lindau disease. Int. J. Mol. Med. 29, 47–52 (2012)PubMed
13.
go back to reference P. Wu, N. Zhang, X. Wang, X. Ning, T. Li, D. BuK, K. Gong, Family history of von Hippel-Lindau disease was uncommon in Chinese patients: suggesting the higher frequency of de novo mutations in VHL gene in these patients. J. Hum. Genet. 57, 238–243 (2012)CrossRefPubMed P. Wu, N. Zhang, X. Wang, X. Ning, T. Li, D. BuK, K. Gong, Family history of von Hippel-Lindau disease was uncommon in Chinese patients: suggesting the higher frequency of de novo mutations in VHL gene in these patients. J. Hum. Genet. 57, 238–243 (2012)CrossRefPubMed
14.
go back to reference J. Chen, W. Geng, Y. Zhao, H. Zhao, G. Wang, F. Huang, F. LiuX, X. Geng, Clinical and mutation analysis of four Chinese families with von Hippel-Lindau disease. Clin. Transl. Oncol. 15, 391–397 (2013)CrossRefPubMed J. Chen, W. Geng, Y. Zhao, H. Zhao, G. Wang, F. Huang, F. LiuX, X. Geng, Clinical and mutation analysis of four Chinese families with von Hippel-Lindau disease. Clin. Transl. Oncol. 15, 391–397 (2013)CrossRefPubMed
15.
go back to reference Y. Gao, Y.P. Huang, X.A. Tu, D.S. Luo, D.H. Wang, S.P. Qiu, P. Xiang, W.Q. Li, R. Jan, Y.Y. Zhang, X.Z. SunC, H. Deng, Genetic characterization and protein stability analysis of a Chinese family with von Hippel-Lindau disease. Chin Med J (Engl) 126, 3690–3693 (2013) Y. Gao, Y.P. Huang, X.A. Tu, D.S. Luo, D.H. Wang, S.P. Qiu, P. Xiang, W.Q. Li, R. Jan, Y.Y. Zhang, X.Z. SunC, H. Deng, Genetic characterization and protein stability analysis of a Chinese family with von Hippel-Lindau disease. Chin Med J (Engl) 126, 3690–3693 (2013)
16.
go back to reference D. Jia, B. Tang, Y. Shi, J. Wang, Z. Sun, Z. Chen, L. Zhang, K. Xia, H. Jiang, A deletion mutation of the VHL gene associated with a patient with sporadic von Hippel-Lindau disease. J Clin Neurosci 20, 842–847 (2013)CrossRefPubMed D. Jia, B. Tang, Y. Shi, J. Wang, Z. Sun, Z. Chen, L. Zhang, K. Xia, H. Jiang, A deletion mutation of the VHL gene associated with a patient with sporadic von Hippel-Lindau disease. J Clin Neurosci 20, 842–847 (2013)CrossRefPubMed
17.
go back to reference Y. Lu, J. Lu, Q. Liu, J. Niu, S.M. Zhang, Q.Y. Wu, X.F. Qi, A c.464T > a mutation in VHL gene in a Chinese family with VHL syndrome. J. Neurooncol. 111, 313–318 (2013)CrossRefPubMed Y. Lu, J. Lu, Q. Liu, J. Niu, S.M. Zhang, Q.Y. Wu, X.F. Qi, A c.464T > a mutation in VHL gene in a Chinese family with VHL syndrome. J. Neurooncol. 111, 313–318 (2013)CrossRefPubMed
18.
go back to reference X.P. Qi, W.T. Liu, J.Y. Li, Y. Dai, J.M. Ma, Y. Zhao, J. Fei, F. Li, M. Shen, H.Y. Jin, Z.G. Chen, Z.F. Du, X.L. Chen, X.N. Zhang, p.N78S and p.R161Q germline mutations of the VHL gene are present in von Hippel-Lindau syndrome in two pedigrees. Mol. Med. Rep. 8, 799–805 (2013)PubMed X.P. Qi, W.T. Liu, J.Y. Li, Y. Dai, J.M. Ma, Y. Zhao, J. Fei, F. Li, M. Shen, H.Y. Jin, Z.G. Chen, Z.F. Du, X.L. Chen, X.N. Zhang, p.N78S and p.R161Q germline mutations of the VHL gene are present in von Hippel-Lindau syndrome in two pedigrees. Mol. Med. Rep. 8, 799–805 (2013)PubMed
19.
go back to reference Y. Su, W.D. Shen, C.C. Wang, W.J. Han, J. Liu, Z.H. Hou, Z.G. Song, D.L. Huang, D.Y. HanS, M. Yang, Endolymphatic sac tumor with von Hippel-Lindau disease: report of two cases with testing of von Hippel-Lindau gene. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 48, 913–918 (2013)PubMed Y. Su, W.D. Shen, C.C. Wang, W.J. Han, J. Liu, Z.H. Hou, Z.G. Song, D.L. Huang, D.Y. HanS, M. Yang, Endolymphatic sac tumor with von Hippel-Lindau disease: report of two cases with testing of von Hippel-Lindau gene. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 48, 913–918 (2013)PubMed
20.
go back to reference X. Ding, C. Zhang, J. M. Frerich, A. Germanwala, C. Yang, R. R. Lonser, Y. Mao, Z. Zhuang, M. Zhang, De novo VHL germline mutation detected in a patient with mild clinical phenotype of von Hippel-Lindau disease. J Neurosurg, (2014) X. Ding, C. Zhang, J. M. Frerich, A. Germanwala, C. Yang, R. R. Lonser, Y. Mao, Z. Zhuang, M. Zhang, De novo VHL germline mutation detected in a patient with mild clinical phenotype of von Hippel-Lindau disease. J Neurosurg, (2014)
21.
go back to reference M. Ohh, C.W. Park, M. Ivan, M.A. Hoffman, T.Y. Kim, L.E. Huang, N. Pavletich, V. ChauW, G. Kaelin, Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat. Cell. Biol. 2, 423–427 (2000)CrossRefPubMed M. Ohh, C.W. Park, M. Ivan, M.A. Hoffman, T.Y. Kim, L.E. Huang, N. Pavletich, V. ChauW, G. Kaelin, Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat. Cell. Biol. 2, 423–427 (2000)CrossRefPubMed
22.
go back to reference J.H. Min, H. Yang, M. Ivan, F. Gertler, W.G. Kaelin Jr, N.P. Pavletich, Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling. Science 296, 1886–1889 (2002)CrossRefPubMed J.H. Min, H. Yang, M. Ivan, F. Gertler, W.G. Kaelin Jr, N.P. Pavletich, Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling. Science 296, 1886–1889 (2002)CrossRefPubMed
23.
go back to reference F. Chen, T. Kishida, M. Yao, T. Hustad, D. Glavac, M. Dean, J.R. Gnarra, M.L. Orcutt, F.M. Duh, G. Glenn et al., Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum. Mutat. 5, 66–75 (1995)CrossRefPubMed F. Chen, T. Kishida, M. Yao, T. Hustad, D. Glavac, M. Dean, J.R. Gnarra, M.L. Orcutt, F.M. Duh, G. Glenn et al., Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum. Mutat. 5, 66–75 (1995)CrossRefPubMed
24.
go back to reference S. Olschwang, S. Richard, C. Boisson, S. Giraud, P. Laurent-Puig, F. Resche, G. Thomas, Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma. Hum. Mutat. 12, 424–430 (1998)CrossRefPubMed S. Olschwang, S. Richard, C. Boisson, S. Giraud, P. Laurent-Puig, F. Resche, G. Thomas, Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic hemangioblastoma. Hum. Mutat. 12, 424–430 (1998)CrossRefPubMed
25.
go back to reference C. Gallou, D. Joly, A. Mejean, F. Staroz, N. Martin, G. Tarlet, M.T. Orfanelli, R. Bouvier, D. Droz, Y. Chretien, J.M. Marechal, S. Richard, C. Junien, C. Beroud, Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC. Hum. Mutat. 13, 464–475 (1999)CrossRefPubMed C. Gallou, D. Joly, A. Mejean, F. Staroz, N. Martin, G. Tarlet, M.T. Orfanelli, R. Bouvier, D. Droz, Y. Chretien, J.M. Marechal, S. Richard, C. Junien, C. Beroud, Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC. Hum. Mutat. 13, 464–475 (1999)CrossRefPubMed
26.
go back to reference S. Glasker, B.U. Bender, T.W. Apel, E. Natt, V. van Velthoven, R. Scheremet, J. ZentnerH, P. Neumann, The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system. J. Neurol. Neurosurg. Psychiatry 67, 758–762 (1999)CrossRefPubMedCentralPubMed S. Glasker, B.U. Bender, T.W. Apel, E. Natt, V. van Velthoven, R. Scheremet, J. ZentnerH, P. Neumann, The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system. J. Neurol. Neurosurg. Psychiatry 67, 758–762 (1999)CrossRefPubMedCentralPubMed
27.
go back to reference C. Mattocks, P. Tarpey, M. BobrowJ, J. Whittaker, Comparative sequence analysis (CSA): a new sequence-based method for the identification and characterization of mutations in DNA. Hum. Mutat. 16, 437–443 (2000)CrossRefPubMed C. Mattocks, P. Tarpey, M. BobrowJ, J. Whittaker, Comparative sequence analysis (CSA): a new sequence-based method for the identification and characterization of mutations in DNA. Hum. Mutat. 16, 437–443 (2000)CrossRefPubMed
28.
go back to reference J.C. Rocha, R.L. Silva, B.B. Mendonca, S. Marui, A.J. Simpson, A.A. Camargo, High frequency of novel germline mutations in the VHL gene in the heterogeneous population of Brazil. J. Med. Genet. 40, e31 (2003)CrossRefPubMedCentralPubMed J.C. Rocha, R.L. Silva, B.B. Mendonca, S. Marui, A.J. Simpson, A.A. Camargo, High frequency of novel germline mutations in the VHL gene in the heterogeneous population of Brazil. J. Med. Genet. 40, e31 (2003)CrossRefPubMedCentralPubMed
29.
go back to reference J.M. Whaley, J. Naglich, L. Gelbert, Y.E. Hsia, J.M. Lamiell, J.S. Green, D. Collins, H.P. Neumann, J. Laidlaw, F.P. Li et al., Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am. J. Hum. Genet. 55, 1092–1102 (1994)PubMedCentralPubMed J.M. Whaley, J. Naglich, L. Gelbert, Y.E. Hsia, J.M. Lamiell, J.S. Green, D. Collins, H.P. Neumann, J. Laidlaw, F.P. Li et al., Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am. J. Hum. Genet. 55, 1092–1102 (1994)PubMedCentralPubMed
30.
go back to reference G. Eisenhofer, H.J. Timmers, J.W. Lenders, S.R. Bornstein, O. Tiebel, M. Mannelli, K.S. King, C.D. Vocke, W.M. Linehan, G. Bratslavsky, K. Pacak, Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location. J. Clin. Endocrinol. Metab. 96, 375–384 (2011)CrossRefPubMedCentralPubMed G. Eisenhofer, H.J. Timmers, J.W. Lenders, S.R. Bornstein, O. Tiebel, M. Mannelli, K.S. King, C.D. Vocke, W.M. Linehan, G. Bratslavsky, K. Pacak, Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location. J. Clin. Endocrinol. Metab. 96, 375–384 (2011)CrossRefPubMedCentralPubMed
Metadata
Title
Von Hippel-Lindau disease type 2 in a Chinese family with a VHL p.W88X truncation
Authors
Min Zhang
Jie Wang
Jingjing Jiang
Xiaohui Zhan
Yan Ling
Zhiqiang Lu
Jianming Guo
Xin Gao
Publication date
01-02-2015
Publisher
Springer US
Published in
Endocrine / Issue 1/2015
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0368-x

Other articles of this Issue 1/2015

Endocrine 1/2015 Go to the issue

Endocrine Imaging

Bladder pheochromocytoma

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.